Patent · US Active

Prevention of N-terminal truncation in IgG light chains

US10618952B2 · kind B2 · utility

0Cited by
0References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2016
Grant dateApr 14, 2020
Priority date
Expiry dateOct 28, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/02
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

We discovered that recombinant antibody light chains having a murine secretory leader sequence and an SYE motif at the N-terminus are truncated during post-translational processing. This disclosure provides two protein engineering solutions: to alter the SYE amino acid sequence of the Lc N-terminus to other alternatives; or to change the secretory leader peptide sequence. We have shown that both of these solutions are effective for preventing N-terminal light chain truncation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.